PROFILE
NIYONSABA François, M.D., Ph.D.
Department of Medical Interpreting
Short Biography
- 1989-1994
- M.D. China Medical University, Liaoning, China
- 1995-1998
- Master’s Degree, Department of Orthopedics, China Medical University, Liaoning,
China
- 1999-2003
- Ph.D., Department of Host Defense and Biochemistry, Graduate School of Medicine,
Juntendo University Graduate School of Medicine
- 2003-2006
- Instructor, Atopy (Allergy) Research Center, Juntendo University Graduate School
of Medicine
- 2006-2007
- Assistant Professor, Atopy (Allergy) Research Center, Juntendo University
Graduate School of Medicine
- 2007-2021
- Associate Professor, Atopy (Allergy) Research Center, Juntendo University
Graduate School of Medicine
- 2010-2011
- Visiting Associate Professor, Department Microbiology and Immunology, University
of British Columbia, Vancouver, Canada
- 2015-2017
- Senior Associate Professor, Global Health Studies, Faculty of International
Liberal Arts, Juntendo University
- 2017-Present
- Professor, Global Health Studies, Faculty of International Liberal Arts,
Juntendo University
- 2021-Present
- Senior Associate Professor, Atopy (Allergy) Research Center, Juntendo University
Graduate School of Medicine
Keywords
- Antimicrobial peptides
- Infections
- Skin Barrier
- Skin Immunology
- Wound Healing
Main Research Topics and Interests
- Roles of Antimicrobial Agents in the Skin Immunity (Graduate School of Medicine)
- Global Infections (Faculty of International Liberal Arts)
Publications (in English)
- Original Articles: 62
- Review Articles: 18
- Books: 3
- h-index: 30 (Web of Science)
- Sum of Times Cited: 3,769 (Web of Science)
Recent Main Publications
- Antimicrobial peptide derived from insulin-like growth factor-binding protein 5
activates mast cells via Mas-related G protein-coupled receptor X2. Allergy 75(1):
203-207; 2020.
- Involvement of the lipoprotein receptor LRP1 in AMP-IBP5-mediated migration and
proliferation of human keratinocytes and fibroblasts. J Dermatol Sci 99(3): 158-167,
2020.
- The antimicrobial peptide human β-defensin-3 accelerates wound healing by promoting
angiogenesis, cell migration and proliferation through the FGFR/JAK2/STAT3 signaling
pathway. Front Immunol 2021 (In press).
- More
Link
